Prosthetic Valve Sweing Ring Injection by Antiboitics Can Affect the Rate of Postoperative Infective Endocarditis?
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Kareem A Hosny
- Phone Number: 01000401994
- Email: kojakkemo@gmail.com
Study Contact Backup
- Name: Amr I Osman
- Phone Number: 01000433878
- Email: dr.amr-osman@outlook.com
Study Locations
-
-
-
Assiut, Egypt, 21557
- Recruiting
- Assiut University
-
Contact:
- Kareem A Hosny
- Phone Number: 01000401994
- Email: kojakkemo@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients who need cardiac valve replacement for rheumatic or degenerative causes
Exclusion Criteria:
- Patients undergoing open heart surgery for any cause other than valve replacement
- patients who are younger than 20 years old.
- Patients undergoing valve repair.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Patients undergoing Cardiac valve replacement
|
injection of sewing ring of prosthetic valve with aminoglycoside
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
number of patients diagnosed with Infective endocarditis post valve replacement
Time Frame: 6 months post operative
|
percentage of post operative clinical and echocardiographic diagnosis of infective endocarditis on prosthetic valve
|
6 months post operative
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- AssiutMedic
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.